scholarly journals CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry

2008 ◽  
Vol 82 (10) ◽  
pp. 5007-5020 ◽  
Author(s):  
Helen J. Harris ◽  
Michelle J. Farquhar ◽  
Christopher J. Mee ◽  
Christopher Davis ◽  
Gary M. Reynolds ◽  
...  

ABSTRACT Hepatitis C virus (HCV) is an enveloped positive-stranded RNA hepatotropic virus. HCV pseudoparticles infect liver-derived cells, supporting a model in which liver-specific molecules define HCV internalization. Three host cell molecules have been reported to be important entry factors or receptors for HCV internalization: scavenger receptor BI, the tetraspanin CD81, and the tight junction protein claudin-1 (CLDN1). None of the receptors are uniquely expressed within the liver, leading us to hypothesize that their organization within hepatocytes may explain receptor activity. Since CD81 and CLDN1 act as coreceptors during late stages in the entry process, we investigated their association in a variety of cell lines and human liver tissue. Imaging techniques that take advantage of fluorescence resonance energy transfer (FRET) to study protein-protein interactions have been developed. Aequorea coerulescens green fluorescent protein- and Discosoma sp. red-monomer fluorescent protein-tagged forms of CD81 and CLDN1 colocalized, and FRET occurred between the tagged coreceptors at comparable frequencies in permissive and nonpermissive cells, consistent with the formation of coreceptor complexes. FRET occurred between antibodies specific for CD81 and CLDN1 bound to human liver tissue, suggesting the presence of coreceptor complexes in liver tissue. HCV infection and treatment of Huh-7.5 cells with recombinant HCV E1-E2 glycoproteins and anti-CD81 monoclonal antibody modulated homotypic (CD81-CD81) and heterotypic (CD81-CLDN1) coreceptor protein association(s) at specific cellular locations, suggesting distinct roles in the viral entry process.

2004 ◽  
Vol 24 (3) ◽  
pp. 259-267 ◽  
Author(s):  
Norio Maeda ◽  
Mamoru Watanabe ◽  
Susumu Okamoto ◽  
Takanori Kanai ◽  
Taketo Yamada ◽  
...  

2012 ◽  
Vol 20 (3) ◽  
pp. 183-192 ◽  
Author(s):  
G. Li ◽  
K. Li ◽  
A. S. Lea ◽  
N. L. Li ◽  
N. E. Abdulla ◽  
...  

2011 ◽  
Vol 46 (2) ◽  
pp. 65-72 ◽  
Author(s):  
Yoshifumi Matsuura ◽  
Hiroshi Yagi ◽  
Sachiko Matsuda ◽  
Osamu Itano ◽  
Koichi Aiura ◽  
...  

2004 ◽  
Vol 85 (11) ◽  
pp. 3173-3188 ◽  
Author(s):  
Peter Simmonds

In the 15 years since the discovery of hepatitis C virus (HCV), much has been learned about its role as a major causative agent of human liver disease and its ability to persist in the face of host-cell defences and the immune system. This review describes what is known about the diversity of HCV, the current classification of HCV genotypes within the family Flaviviridae and how this genetic diversity contributes to its pathogenesis. On one hand, diversification of HCV has been constrained by its intimate adaptation to its host. Despite the >30 % nucleotide sequence divergence between genotypes, HCV variants nevertheless remain remarkably similar in their transmission dynamics, persistence and disease development. Nowhere is this more evident than in the evolutionary conservation of numerous evasion methods to counteract the cell's innate antiviral defence pathways; this series of highly complex virus–host interactions may represent key components in establishing its ‘ecological niche’ in the human liver. On the other hand, the mutability and large population size of HCV enables it to respond very rapidly to new selection pressures, manifested by immune-driven changes in T- and B-cell epitopes that are encountered on transmission between individuals with different antigen-recognition repertoires. If human immunodeficiency virus type 1 is a precedent, future therapies that target virus protease or polymerase enzymes may also select very rapidly for antiviral-resistant mutants. These contrasting aspects of conservatism and adaptability provide a fascinating paradigm in which to explore the complex selection pressures that underlie the evolution of HCV and other persistent viruses.


1992 ◽  
Vol 37 (4) ◽  
pp. 310-314 ◽  
Author(s):  
Richard Sallie ◽  
Anne Rayner ◽  
Bernard Portmann ◽  
A. L. W. F. Eddleston ◽  
Roger Williams

1983 ◽  
Vol 48 (6) ◽  
pp. 791-796 ◽  
Author(s):  
M J Iqbal ◽  
M L Wilkinson ◽  
P J Johnson ◽  
R Williams

Sign in / Sign up

Export Citation Format

Share Document